Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 2.23331 | 9 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 2.21626 | 9 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 2.21649 | 9 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 2.16986 | 9 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 2.16346 | 9 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 2.27176 | 9 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 2.21726 | 8 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 2.19382 | 9 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 2.18677 | 9 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 2.20459 | 9 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 2.20101 | 9 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 2.19149 | 9 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 2.20917 | 9 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 2.20524 | 9 |